Literature DB >> 20139761

Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.

Alcides Chaux1, Rolf Pfannl, Belén Lloveras, María Alejo, Omar Clavero, Cecilia Lezcano, Nubia Muñoz, Silvia de Sanjosé, Xavier Bosch, Marier Hernández-Pérez, Elsa F Velazquez, Antonio L Cubilla.   

Abstract

From the pathogenic point of view, penile cancers may be grouped in human papillomavirus-related and unrelated tumors, each one of them with distinctive morphologic features. The former are predominantly composed of small, undifferentiated basaloid cells, with more or less prominent koilocytic changes, and the latter of keratinizing differentiated squamous cells. The same cellular types are observed in precancerous lesions. On the basis of these observations, we constructed a novel nomenclature for penile precancerous lesions and classified them as penile intraepithelial neoplasia (PeIN) of differentiated, warty, basaloid, and warty-basaloid types. The aim of this study was to test the usefulness of immunohistochemical p16 overexpression, considered as a surrogate for high-risk human papillomavirus infection, using this classification system. We pathologically evaluated 141 patients with PeIN, associated (123 cases) and unassociated (18 cases) with invasive cancer. Distribution of PeIN types was: differentiated, 72%; basaloid, 9%; warty-basaloid, 7%; warty, 4%; and mixed, 7%. There was a striking similarity in the morphology of in situ and invasive squamous cell carcinomas. Differentiated PeIN was commonly associated with usual, verrucous, papillary, and other low-grade keratinizing variants of squamous cell carcinoma whereas in basaloid and warty carcinomas the presence of in situ lesions with similar morphology was habitual. We evaluated p16 overexpression using a 4-tiered (0, 1, 2, and 3) pattern-based system. To properly distinguish differentiated PeIN from in situ lesions with warty and/or basaloid features only pattern 3, which requires full-thickness staining in all epithelial cells, was considered positive. Using this approach, there was a significant association of the negative patterns and differentiated PeIN and of the positive pattern and warty, basaloid, and warty-basaloid PeIN (P<0.0001). Basaloid variant had the strongest association. The sensitivity rate of p16 positivity for discriminating types of PeIN was of 82%, with a specificity of 100% and an accuracy of 95%. Lichen sclerosus was identified in 42 cases and their epithelial component was p16 negative in all cases. Although more studies are necessary to confirm these observations, p16 overexpression seems to be a useful tool for discriminating differentiated from warty, basaloid, and warty-basaloid PeIN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139761     DOI: 10.1097/PAS.0b013e3181cdad23

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Infectious disease: The natural history of HPV infection in men.

Authors:  María José Fernández-Nestosa; Antonio L Cubilla
Journal:  Nat Rev Urol       Date:  2015-08-11       Impact factor: 14.432

Review 2.  Male genital premalignant dermatoses.

Authors:  Oliver Kayes; Majid Shabbir; Suks Minhas
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

3.  Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence.

Authors:  José Vassallo; André Fellipe Freitas Rodrigues; Antonio Hugo J F M Campos; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Stênio Cássio Zequi; Gustavo Cardoso Guimarães; Francisco Paulo da Fonseca; Ademar Lopes; Antonio Cubilla; Fernando Augusto Soares
Journal:  Tumour Biol       Date:  2015-01-05

4.  Prevalence of human papillomavirus and implication on survival in Chinese penile cancer.

Authors:  Chengbiao Chu; Keming Chen; Xingliang Tan; Jiangli Lu; Yuanzhong Yang; YiJun Zhang; Kai Yao; Yun Cao
Journal:  Virchows Arch       Date:  2020-05-19       Impact factor: 4.064

5.  Diagnosis and management of premalignant penile lesions.

Authors:  Majid Shabbir; Suks Minhas; Asif Muneer
Journal:  Ther Adv Urol       Date:  2011-06

6.  HPV-negative Penile Intraepithelial Neoplasia (PeIN) With Basaloid Features.

Authors:  José Guerrero; Isabel Trias; Luis Veloza; Marta Del Pino; Adriana Garcia; Lorena Marimon; Sherley Diaz-Mercedes; Maria T Rodrigo-Calvo; Silvia Alós; Tarek Ajami; Rafael Parra-Medina; Antonio Martinez; Oscar Reig; Maria J Ribal; Juan M Corral-Molina; Jaume Ordi; Inmaculada Ribera-Cortada; Natalia Rakislova
Journal:  Am J Surg Pathol       Date:  2022-03-17       Impact factor: 6.298

7.  The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.

Authors:  Julie Steinestel; Andreas Al Ghazal; Annette Arndt; Thomas J Schnoeller; Andres J Schrader; Peter Moeller; Konrad Steinestel
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

Review 8.  Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity.

Authors:  Aditya Manjunath; Thomas Brenton; Sarah Wylie; Catherine M Corbishley; Nick A Watkin
Journal:  Transl Androl Urol       Date:  2017-10

9.  Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.

Authors:  Inmaculada Ribera-Cortada; José Guerrero-Pineda; Isabel Trias; Luis Veloza; Adriana Garcia; Lorena Marimon; Sherley Diaz-Mercedes; José Ramon Alamo; Maria Teresa Rodrigo-Calvo; Naiara Vega; Ricardo López Del Campo; Rafael Parra-Medina; Tarek Ajami; Antonio Martínez; Oscar Reig; Maria J Ribal; Juan Manuel Corral-Molina; Pedro Jares; Jaume Ordi; Natalia Rakislova
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

10.  Immunotherapy for penile cancer.

Authors:  Carlo Buonerba; Martina Pagliuca; Francesca Maria Vitrone; Ilaria Ascione; Ivana Elefante; Vittorio Riccio; Francesca Romano; Sabino De Placido; Giuseppe Di Lorenzo
Journal:  Future Sci OA       Date:  2017-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.